At the next hearing, he stood, the email in hand. “Your Honor, the defense claims that any data irregularities were accidental. However, we now possess a written admission from the very individual responsible for the statistical analysis, acknowledging intentional manipulation to meet an artificial endpoint.”
But a whistleblower—a former lab technician named —had slipped a flash drive into Marlowe’s inbox, containing evidence that NeuroVita ’s clinical trial data had been fabricated . The stakes were no longer just legal; they were ethical, scientific, and deeply personal.
Alex smiled back, her heart racing with satisfaction. "You're welcome, Jade. Justice has been served." lawyer vs pro part 2 jade kush
Victor Haines rose, his composure cracking. “Objection—this is hearsay.”
During the night of the recess, Tara’s team hacked—legally, through a —the email archives of Dr. Patel, the biostatistician. Buried among routine correspondence was a single email, timestamped exactly one week before the data lock, addressed to an external consultant: At the next hearing, he stood, the email in hand
The courtroom was a sleek arena of polished wood and digital displays. At the plaintiff’s table, Marlowe stood beside his client, , the neurologist who had first raised alarms about the trial’s irregularities. Across the aisle, Jade Kush sat poised, her silver‑threaded suit catching the light, a calm smile playing on her lips. Beside her, Victor Haines , the formidable chief legal strategist for KushBio, shuffled a stack of glossy presentation slides.
“I’ve adjusted the ‘treated’ arm scores by +0.7 to meet the primary endpoint. The regulators will never see the raw file. Let’s discuss compensation after the product launch.” The stakes were no longer just legal; they
"Not guilty," the foreman announced.
The judge called for a short recess, allowing both sides to regroup.
After three days of closing arguments, the jurors retreated to deliberate. The city buzzed with speculation: would the court punish an entire biotech empire for the sins of a single employee, or would it recognize the broader societal value of NeuroVita ?
In a surprise move, stepped forward, not as a corporate figurehead but as a scientist. She displayed a newly released pre‑print from an independent university that replicated NeuroVita ’s core mechanism in a mouse model, showing promising results.